𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Sirolimus Conversion Regimen Versus Continued Calcineurin Inhibitors in Liver Allograft Recipients: A Randomized Trial

✍ Scribed by M. F. Abdelmalek; A. Humar; F. Stickel; P. Andreone; A. Pascher; E. Barroso; G. W. Neff; D. Ranjan; L. T. Toselli; E. J. Gane; J. Scarola; R. Goldberg-Alberts; E. S. Maller; C.-M. Lo; for the Sirolimus Liver Conversion Trial Study Group

Book ID
114806325
Publisher
John Wiley and Sons
Year
2012
Tongue
English
Weight
740 KB
Volume
12
Category
Article
ISSN
1600-6135

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Conversion from a calcineurin inhibitor
Conversion from a calcineurin inhibitor to everolimus therapy in maintenance liver transplant recipients: A prospective, randomized, multicenter trial
✍ Paolo De Simone; Herold J. Metselaar; Lutz Fischer; JΓ©rΓ΄me Dumortier; Karim Boud πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 220 KB

Calcineurin inhibitors (CNIs) contribute to renal dysfunction following liver transplantation. This prospective, randomized, multicenter, 6-month study (with an additional 6 months of follow-up) evaluated whether everolimus with CNI reduction or discontinuation would improve renal function in mainte

A randomized controlled trial of late co
A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)-based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function
✍ Christopher J.E. Watson; Alexander E.S. Gimson; Graeme J. Alexander; Michael E.D πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 307 KB πŸ‘ 1 views

Renal impairment is common in patients after liver transplantation and is attributable in large part to the use of calcineurin inhibitor (CNI)-based immunosuppression. We sought to determine whether conversion to sirolimus-based immunosuppression was associated with improved renal function. In a sin